These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Malignant hyperthermia. Rosenberg H; Davis M; James D; Pollock N; Stowell K Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235 [TBL] [Abstract][Full Text] [Related]
5. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript. Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402 [TBL] [Abstract][Full Text] [Related]
6. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations. Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893 [TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review. Kraeva N; Sapa A; Dowling JJ; Riazi S Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467 [TBL] [Abstract][Full Text] [Related]
8. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing and bioinformatics to identify genetic causes of malignant hyperthermia. Yeh HM; Liao MH; Chu CL; Lin YH; Sun WZ; Lai LP; Chen PL J Formos Med Assoc; 2021 Feb; 120(2):883-892. PubMed ID: 32919876 [TBL] [Abstract][Full Text] [Related]
10. Atypical symptoms of malignant hyperthermia: A rare causative mutation in the RYR1 gene. Wang QL; Fang Y; Jin SG; Liang JT; Ren YF Open Med (Wars); 2022; 17(1):239-244. PubMed ID: 35178478 [TBL] [Abstract][Full Text] [Related]
11. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989 [TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084 [TBL] [Abstract][Full Text] [Related]
14. Increasing the number of diagnostic mutations in malignant hyperthermia. Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329 [TBL] [Abstract][Full Text] [Related]
15. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations. Carsana A ScientificWorldJournal; 2013; 2013():531465. PubMed ID: 23476141 [TBL] [Abstract][Full Text] [Related]
16. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations. Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662 [TBL] [Abstract][Full Text] [Related]
18. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019. Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029 [TBL] [Abstract][Full Text] [Related]
19. Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes. Keating KE; Giblin L; Lynch PJ; Quane KA; Lehane M; Heffron JJ; McCarthy TV J Med Genet; 1997 Apr; 34(4):291-6. PubMed ID: 9138151 [TBL] [Abstract][Full Text] [Related]